ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Zimmer Biomet Holdings, Inc. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 2.19% and Operating profit at 14.17% over the last 5 years
2
Negative results in Jun 25
- NET PROFIT(9M) At USD 753.55 MM has Grown at -28.26%
- INTEREST COVERAGE RATIO(Q) Lowest at 869.79
- DEBT-EQUITY RATIO (HY) Highest at 56.01 %
3
With ROCE of 7.93%, it has a fair valuation with a 1.85 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -13.53%, its profits have fallen by -7.2%
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -13.53% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Zimmer Biomet Holdings, Inc. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Zimmer Biomet Holdings, Inc.
-4.38%
-0.58
30.95%
S&P 500
17.36%
0.70
20.15%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
3.22%
EBIT Growth (5y)
10.25%
EBIT to Interest (avg)
6.38
Debt to EBITDA (avg)
2.71
Net Debt to Equity (avg)
0.47
Sales to Capital Employed (avg)
0.40
Tax Ratio
12.92%
Dividend Payout Ratio
27.05%
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
6.76%
ROE (avg)
8.16%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
29
Industry P/E
Price to Book Value
2.48
EV to EBIT
26.24
EV to EBITDA
15.27
EV to Capital Employed
1.95
EV to Sales
4.85
PEG Ratio
NA
Dividend Yield
32.65%
ROCE (Latest)
7.42%
ROE (Latest)
8.51%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 1,697.1 MM
DIVIDEND PAYOUT RATIO(Y)
Highest at 34.13%
CASH AND EQV(HY)
Highest at USD 1,884.6 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 1.42 times
NET SALES(Q)
Highest at USD 2,243.8 MM
-17What is not working for the Company
INTEREST COVERAGE RATIO(Q)
Lowest at 798.45
INTEREST(HY)
At USD 144.8 MM has Grown at 31.04%
ROCE(HY)
Lowest at 5.6%
RAW MATERIAL COST(Y)
Grown by 9.96% (YoY
DEBT-EQUITY RATIO
(HY)
Highest at 56.39 %
DEBTORS TURNOVER RATIO(HY)
Lowest at 5.17 times
OPERATING PROFIT(Q)
Lowest at USD 566.9 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 25.27 %
PRE-TAX PROFIT(Q)
Lowest at USD 231.5 MM
EPS(Q)
Lowest at USD 0.7
Here's what is working for Zimmer Biomet Holdings, Inc.
Operating Cash Flow
Highest at USD 1,697.1 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
Highest at USD 2,243.8 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Cash and Eqv
Highest at USD 1,884.6 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Inventory Turnover Ratio
Highest at 1.42 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Dividend Payout Ratio
Highest at 34.13%
in the last five yearsMOJO Watch
Company is distributing higher proportion of profits generated as dividend
DPR (%)
Depreciation
Highest at USD 284 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for Zimmer Biomet Holdings, Inc.
Interest Coverage Ratio
Lowest at 798.45 and Fallen
In each period in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Interest
At USD 144.8 MM has Grown at 31.04%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Operating Profit
Lowest at USD 566.9 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Operating Profit Margin
Lowest at 25.27 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at USD 231.5 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Pre-Tax Profit
Fallen at -35.06%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
EPS
Lowest at USD 0.7
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (USD)
Debt-Equity Ratio
Highest at 56.39 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Debtors Turnover Ratio
Lowest at 5.17 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 9.96% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
